A multicentre phase-II trial of thalidomide in relapsed/refractory multiple myeloma (MM) reveals a dominant adverse prognostic impact of advanced age.

被引：0
|
作者：
Prince, M
Mileshkin, L
Biagi, JJ
Smith, JG
Mitchell, P
Underhill, C
Grigg, A
Bell, R
McKendrick, J
Briggs, P
Seymour, JF
Simmons, PJ
Zeldis, JB
机构：
[1] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[2] Austin Repatriat Med Ctr, Heidelberg, Vic, Australia
[3] Border Med Oncol, Wodonga, Australia
[4] Royal Melbourne Hosp, Melbourne, Vic, Australia
[5] Geelong Hosp, Geelong, Vic, Australia
[6] Box Hill Hosp, Box Hill, Australia
[7] Monash Med Ctr, Clayton, Vic 3168, Australia
[8] Celgene Corp, Wayne, NJ 07059 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：401A / 402A
页数：2
相关论文
共 50 条
  • [1] Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age
    Mileshkin, L
    Biagi, JJ
    Mitchell, P
    Underhill, C
    Grigg, A
    Bell, R
    McKendrick, J
    Briggs, P
    Seymour, JF
    Lillie, K
    Smith, JG
    Zeldis, JB
    Prince, HM
    BLOOD, 2003, 102 (01) : 69 - 77
  • [2] A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma
    Glasmacher, A
    Hahn, C
    Hoffmann, F
    Naumann, R
    Goldschmidt, H
    Lilienfeld-Toal, M
    Orlopp, K
    Schmidt-Wolf, I
    Gorschlüter, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (05) : 584 - 593
  • [3] A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma
    Prince, HM
    Mileshkin, L
    Roberts, A
    Ganju, V
    Underhill, C
    Catalano, J
    Bell, R
    Seymour, JF
    Westerman, D
    Simmons, PJ
    Lillie, K
    Milner, AD
    Di Iulio, J
    Zeldis, JB
    Ramsay, R
    CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5504 - 5514
  • [4] Phase II study of thalidomide with dexamethasone for relapsed/refractory multiple myeloma
    Kinoshita, T
    Ohno, T
    Yuge, M
    Hiraga, J
    Matsushita, T
    Ando, S
    Naoe, T
    ANNALS OF ONCOLOGY, 2005, 16 : 206 - 206
  • [5] A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Lee, Hans C.
    Shah, Jatin J.
    Feng, Lei
    Morphey, Ashley
    Johnson, Ralph J.
    Wesson, Emily T.
    Wang, Michael L.
    Alexanian, Raymond
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Weber, Donna M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : E319 - E322
  • [6] A phase II trial of thalidomide in the treatment of relapsed multiple myeloma (MM) with laboratory correlative studies.
    Rajkumar, SV
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Geyer, S
    Wellik, L
    Hayman, S
    Lust, JA
    Kyle, RA
    Greipp, PR
    Gertz, MA
    Witzig, TE
    BLOOD, 2000, 96 (11) : 168A - 168A
  • [7] The adverse prognostic impact of advanced age in multiple myeloma
    Mileshkin, L
    Prince, HM
    LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 951 - 966
  • [8] Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma.
    Somlo, G
    Bellamy, W
    Zimmerman, TM
    Frankel, P
    Tuscano, J
    O'Donnell, M
    Mohrbacher, A
    Forman, S
    Chen, H
    Doroshow, J
    Gandara, D
    BLOOD, 2005, 106 (11) : 723A - 723A
  • [9] Phase I Trial of the Combination of Lenalidomide, Thalidomide and Dexamethasone In Relapsed/Refractory Multiple Myeloma
    Shah, Jatin J.
    Orlowski, Robert Z.
    Alexanian, Raymond
    Wang, Michael
    Thomas, Sheeba
    Qazilbash, Muzaffar H.
    Parmar, Simrit
    Shah, Nina
    Bashir, Qaiser
    Popat, Uday
    Weber, Donna
    BLOOD, 2010, 116 (21) : 811 - 812
  • [10] Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
    Palumbo, Antonio
    Larocca, Alessandra
    Genuardi, Mariella
    Kotwica, Katarzyna
    Gay, Francesca
    Rossi, Davide
    Benevolo, Giulia
    Magarotto, Valeria
    Cavallo, Federica
    Bringhen, Sara
    Rus, Cecilia
    Masini, Luciano
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Anderson, Kenneth
    Boccadoro, Mario
    Richardson, Paul
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1144 - 1149
12345